The role of chaperone proteins in autoimmunity.

PubWeight™: 0.88‹?›

🔗 View Article (PMID 17192556)

Published in Ann N Y Acad Sci on November 01, 2006

Authors

John G Routsias1, Athanasios G Tzioufas

Author Affiliations

1: Department of Pathophysiology, School of Medicine, University of Athens, 11527 Athens, Greece.

Articles by these authors

Treatment of primary Sjögren syndrome: a systematic review. JAMA (2010) 2.37

Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active Rheumatoid Arthritis (ReAct) trial. Ann Rheum Dis (2007) 1.83

Properties and function of polyreactive antibodies and polyreactive antigen-binding B cells. J Autoimmun (2007) 1.71

Upregulation of antiphospholipid antibodies following cyclophosphamide therapy in patients with systemic lupus erythematosus. J Rheumatol (2008) 1.47

Classification criteria for Sjogren's syndrome: a critical review. J Autoimmun (2011) 1.46

Pathogenetic mechanisms in the initiation and perpetuation of Sjögren's syndrome. Nat Rev Rheumatol (2010) 1.43

Performance of the preliminary classification criteria for cryoglobulinaemic vasculitis and clinical manifestations in hepatitis C virus-unrelated cryoglobulinaemic vasculitis. Clin Exp Rheumatol (2012) 1.41

Longterm followup after tapering mycophenolate mofetil during maintenance treatment for proliferative lupus nephritis. J Rheumatol (2011) 1.39

Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta-analysis. Arthritis Rheum (2006) 1.21

Topical and systemic medications for the treatment of primary Sjögren's syndrome. Nat Rev Rheumatol (2012) 1.19

Sjögren's syndrome--study of autoantigens and autoantibodies. Clin Rev Allergy Immunol (2007) 1.16

Classification criteria for Sjogren's syndrome: we actually need to definitively resolve the long debate on the issue. Ann Rheum Dis (2012) 1.14

Precise probes of type II interferon activity define the origin of interferon signatures in target tissues in rheumatic diseases. Proc Natl Acad Sci U S A (2012) 1.10

Prognosis and outcome of non-Hodgkin lymphoma in primary Sjögren syndrome. Medicine (Baltimore) (2012) 1.09

Idiotype-anti-idiotype circuit in non-autoimmune mice after immunization with the epitope and complementary epitope 289-308aa of La/SSB: implications for the maintenance and perpetuation of the anti-La/SSB response. J Autoimmun (2003) 1.09

Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases. J Autoimmun (2006) 1.07

Selective screening of secretory vesicle-associated proteins for autoantigens in type 1 diabetes: VAMP2 and NPY are new minor autoantigens. Clin Immunol (2008) 1.06

Efficacy and long-term follow-up of IL-1R inhibitor anakinra in adults with Still's disease: a case-series study. Arthritis Res Ther (2011) 1.04

Autoantibodies to intracellular autoantigens and their B-cell epitopes: molecular probes to study the autoimmune response. Crit Rev Clin Lab Sci (2006) 1.00

Predictors of sustained amenorrhea from pulsed intravenous cyclophosphamide in premenopausal women with systemic lupus erythematosus. J Rheumatol (2002) 0.98

Unmasking the anti-La/SSB response in sera from patients with Sjogren's syndrome by specific blocking of anti-idiotypic antibodies to La/SSB antigenic determinants. Mol Med (2002) 0.98

Hepatitis C virus, Sjögren's syndrome and B-cell lymphoma: linking infection, autoimmunity and cancer. Autoimmun Rev (2005) 0.97

Prevalence of hepatitis C serum antibody in autoimmune diseases. J Autoimmun (2009) 0.94

The clinical value of intracellular autoantigens B-cell epitopes in systemic rheumatic diseases. Clin Chim Acta (2004) 0.92

Clinically significant renal involvement in primary Sjögren's syndrome: clinical presentation and outcome. Arthritis Rheum (2013) 0.91

Low levels of vitamin-D are associated with neuropathy and lymphoma among patients with Sjögren's syndrome. J Autoimmun (2012) 0.91

Cellular microRNAs (miRNAs) and Sjögren's syndrome: candidate regulators of autoimmune response and autoantigen expression. J Autoimmun (2011) 0.91

Autoimmune response and target autoantigens in Sjogren's syndrome. Eur J Clin Invest (2010) 0.90

RNA recognition motif (RRM) of La/SSB: the bridge for interparticle spreading of autoimmune response to U1-RNP. Mol Med (2009) 0.87

Incidence and prevalence of major central nervous system involvement in systemic lupus erythematosus: a 3-year prospective study of 370 patients. PLoS One (2013) 0.87

The effect of anakinra, an IL1 receptor antagonist, in patients with sporadic inclusion body myositis (sIBM): a small pilot study. J Neurol Sci (2013) 0.86

Fine epitope specificity of anti-erythropoietin antibodies reveals molecular mimicry with HIV-1 p17 protein: a pathogenetic mechanism for HIV-1-related anemia. J Infect Dis (2011) 0.86

B-cell epitopes of the intracellular autoantigens Ro/SSA and La/SSB: tools to study the regulation of the autoimmune response. J Autoimmun (2010) 0.85

Minor salivary gland inflammatory lesions in Sjögren syndrome: do they evolve? J Rheumatol (2013) 0.84

Peripheral neuropathies in Sjogren syndrome: a new reappraisal. J Neurol Neurosurg Psychiatry (2010) 0.84

Anti-La/SSB antiidiotypic antibodies in maternal serum: a marker of low risk for neonatal lupus in an offspring. Arthritis Rheum (2006) 0.84

The efficacy of canakinumab in the treatment of a patient with familial Mediterranean fever and longstanding destructive arthritis. Ann Rheum Dis (2011) 0.82

Association of the idiotype:antiidiotype antibody ratio with the efficacy of intravenous immunoglobulin treatment for the prevention of recurrent autoimmune-associated congenital heart block. Arthritis Rheum (2011) 0.80

Zinc ion dependent B-cell epitope, associated with primary Sjogren's syndrome, resides within the putative zinc finger domain of Ro60kD autoantigen: physical and immunologic properties. J Med Chem (2004) 0.80

Linear epitopes of two different autoantigens-La/SSB and myelin basic protein--with a high degree of molecular similarity, cause different humoral immune responses. J Autoimmun (2003) 0.80

Lymphoma development in a patient receiving anti-TNF therapy. Haematologica (2003) 0.80

Mycophenolate mofetil as maintenance therapy for proliferative lupus nephritis: a long-term observational prospective study. Arthritis Res Ther (2010) 0.78

Current Aspects of Pathogenesis in Sjögren's Syndrome. Ther Adv Musculoskelet Dis (2010) 0.78

Acquired angioedema: a new target for rituximab? Haematologica (2004) 0.77

Indications for bone marrow examination in autoimmune disorders with concurrent haematologic alterations. Clin Exp Rheumatol (2012) 0.76

Clinical and laboratory predictors of distinct histopathogical features of lupus nephritis. Medicine (Baltimore) (2015) 0.75

Immunization of mice with a peptide derived from the HTLV-1 TAX1BP1 protein induces cross-reactive antibodies against aquaporin 4. Autoimmunity (2015) 0.75

Periodic fevers in adult Greeks: clinical and molecular presentation. Clin Exp Rheumatol (2014) 0.75

Functional expression of the alpha 2-macroglobulin receptor CD91 in salivary gland epithelial cells. J Autoimmun (2009) 0.75

[Sjögren syndrome. New therapeutic approaches]. Med Clin (Barc) (2005) 0.75

B-cell chronic lymphocytic leukaemia presenting as lower motor neuron disease and SS. Rheumatology (Oxford) (2012) 0.75

Human chorionic gonadotropin prevents Sjögren's syndrome-like exocrinopathy in mice. Arthritis Rheum (2007) 0.75

Demographics, clinical characteristics and predictive factors for total knee or hip replacement in patients with rheumatoid arthritis in Greece. Clin Exp Rheumatol (2012) 0.75